TruBridge Announces First Quarter 2025 Conference Call to Be Held Wednesday, May 7, 2025
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced that it will release its financial results for the first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. The Company will host a conference call at 3:30 p.m. Central Time, 4:30 p.m. Eastern Time the same day. To access this interactive teleconference, dial (888) 396-8049 and request connection to the TruBridge earnings conference call.
A live broadcast of TruBridge's conference call will also be available online at the Company's website, www.trubridge.com. The 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.
About TruBridge
We are a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. Our industry leading HFMA Peer Reviewed ® suite of revenue cycle management (RCM) offerings combine unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative solutions that create real value by supporting both the financial and clinical side of healthcare delivery. Our solutions champion end-to-end, data-driven patient journeys that support value-based care, improve outcomes, and increase patient satisfaction. We support efficient patient care with electronic health record (EHR) product offerings that successfully integrate data between care settings. Above all, we believe in the power of community and encourage collaboration, connection, and empowerment with our customers. We clear the way for care. For more information, please visit www.trubridge.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Fraudulent OB/GYN sentenced to 10 years in prison
CHICAGO — A fraudulent OB/GYN, who pleaded guilty last summer for bilking Medicaid and private insurance, has been sentenced to 10 years in prison. Dr. Mona Ghosh owned Progressive Women's Healthcare, located in Hoffman Estates, and was accused of submitting fraudulent claims to Medicaid and other private insurance companies from 2018 to 2022. A total of 17 women spoke during the federal sentencing hearings, which concluded Monday morning after being adjourned on May 29. Several women told stories of how Ghosh charged their insurance companies for visits that didn't happen. Others described the unnecessary tests and procedures she performed. 'I felt like she supported me. In turn, when I'm finding the medical bills coming back for things that never happened, she fed on my vulnerability, on my weakness,' a woman said. Several women shared that they went to Ghosh for a routine pap smear, or cervical cancer screening, and were told results were abnormal. Fearful that they could have cancer, they agreed to get a biopsy. Witnesses said while they were sedated, Ghosh performed other procedures instead, including ones they said have affected their fertility. 17 women share emotional experiences during sentencing of fraudulent OB/GYN Ghosh directed her own employees to submit the fraudulent claims as well. She admitted in the plea agreement that she is accountable for more than $1.5 million. The judge Monday ordered restitution to insurance providers of $1.5 million. Restitution to the victims was ordered in the amount of $605.02. The judge explained that he could only impose restitution to patients based on actual losses for unnecessary and unwanted procedures under specific situations. She has surrendered her medical license and must serve a minimum of two years before being eligible for supervised release. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
12 minutes ago
- Yahoo
Congress should think again about foreign investor tax: UK ambassador to US
British Ambassador to the U.S. Peter Mandelson is appealing to Congress to think again about the proposed new retaliatory tax on certain foreign investment in the US. 'I think that there's something wrong in principle that you should punish a country's businesses and individuals in America because you don't like what their governments are doing at home,' Mandelson said of Section 899 of the House's 'big, beautiful bill' to implement Trump's agenda. Section 899 would create a retaliatory tax on nationals of countries that impose 'unfair foreign taxes' on American businesses. 'If you've got an argument with their governments, then take it out on the governments. Don't take it out on the businesses and the individuals,' he added. Mandelson also believes that this new foreign investor tax is 'counterproductive' for the United States. 'If you're creating such a risk or potential uncertainty tax on businesses here, then many will think twice about investing further in the United States. I would ask Congress to think again about 899,' he said. According to Mandelson, both Congress and the Trump administration should resolve these matters by negotiation, and 'not by means of a legislative bludgeon', where he says the 'innocent are being punished because it's felt that revenge is due against a country and it's taken out on businesses and individuals here in the US.' He added that Section 899 also sets a 'very difficult precedent,' and it's better resolved by 'government to government negotiation and by discretionary means, not statutory ones.' The provision has stoked concerns on Wall Street over whether foreign investors would pull out of U.S. investments over fears of retribution from Trump. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
18 minutes ago
- Yahoo
Musk-Trump Space Showdown Sends Rocket Lab Shares Soaring
June 9 - Rocket Lab USA Inc (NASDAQ:RKLB) shares climbed about 8% on Monday as investors reacted to a weekend spat between SpaceX CEO Elon Musk and former President Donald Trump. The feud began when Musk criticized Trump's proposed tax legislation on X, prompting Trump to suggest cutting Musk's government contracts. Musk fired back, hinting he might decommission SpaceX's Dragon spacecraft, currently the only U.S. vehicle for ferrying astronauts to the International Space Station, before retracting the comment. Over the weekend, Musk posted that we have got the spaceships, and they do not, implying U.S. reliance on SpaceX. That argument appears to be fueling interest in rival aerospace firms. RKLB, which holds multiple NASA contracts and is viewed as a contender for Trump's $175 billion Golden Dome missile defense initiative, saw its stock hit $31.21 in morning trading. AST SpaceMobile Inc (NASDAQ:ASTS) shares surged about 17% after reports suggested U.S. policymakers may look beyond SpaceX for various space investments. ASTS, a top customer of Blue Origin, inked a November launch deal with Jeff Bezos' company to deploy up to 45 satellites. Both RKLB and ASTS traded on above-average volume, signaling heightened investor focus on alternative space players amid the high-profile Musk-Trump clash. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
